Coronavirus Impact on Imports Expected to be Larger and Last Longer Than Previously Expected

“There are still a lot of unknowns to fully determine the impact of the coronavirus on the supply chain,” NRF Vice President for Supply Chain and Customs Policy Jonathan Gold said. “As factories in China continue to come back online, products are now flowing again. But there are still issues affecting cargo movement, including the availability of truck drivers to move cargo to Chinese ports. Retailers are working with both their suppliers and transportation providers to find paths forward to minimize disruption.”

“Now that we are in the coronavirus environment, uncertainty has expanded exponentially,” Hackett Associates Founder Ben Hackett said. “Our projections are based on the optimistic view that by the end of March or early April some sort of normalcy will have returned to trade.”

This month’s report comes as a separate NRF survey of members found 40 percent of respondents said they are seeing disruptions to their supply chains from the virus and that another 26 percent expect to see disruptions as the situation continues.

U.S. ports covered by Global Port Tracker handled 1.82 million Twenty-Foot Equivalent Units in January, the latest month for which after-the-fact numbers are available. That was up 5.7 percent from December but down 3.8 percent from unusually high numbers a year ago related to U.S. tariffs on goods from China. A TEU is one 20-foot-long cargo container or its equivalent.

February was estimated at 1.42 million TEU, slightly above the 1.41 million TEU expected a month ago but down 12.6 percent from last year and significantly lower than the 1.54 million TEU forecast before the coronavirus began to have an effect on imports. March is forecast at 1.32 million TEU, down 18.3 percent from last year and less than the 1.46 million TEU expected last month or the 1.7 million TEU forecast before the virus.

April, which had not previously been expected to be affected, is now forecast at 1.68 million TEU, down 3.5 percent from last year and lower than the 1.82 million TEU forecast last month.

While the coronavirus makes forecasting difficult, the report calls for imports to jump to 2.02 million TEU in May, a 9.3 percent increase year-over-year, on the assumption that Chinese factories will have resumed most production by then and will be trying to make up for lower volume earlier. June is forecast at 1.97 million TEU, up 9.6 percent year-over-year, and July is forecast at 2.03 million TEU, up 3.3 percent year-over-year.

Imports during 2019 totaled 21.6 million TEU, a 0.8 percent decrease from 2018 amid the ongoing trade war but still the second-highest year on record. The first half of 2020 is forecast to total 10.23 million TEU, down 2.8 percent from the same period last year and below the 10.47 million TEU forecast a month ago.

Global Port Tracker, which is produced for NRF by the consulting firm Hackett Associates, provides historical data and forecasts for the U.S. ports of Los Angeles/Long Beach, Oakland, Seattle and Tacoma on the West Coast; New York/New Jersey, Port of Virginia, Charleston, Savannah, Port Everglades, Miami and Jacksonville on the East Coast, and Houston on the Gulf Coast. The report is free to NRF retail members, and subscription information is available at NRF.com/PortTracker or by calling (202) 783-7971. Subscription information for non-members can be found at www.globalporttracker.com.

SourceNRF

Hot this week

Medtronic Expands AiBLE Spine Surgery Ecosystem with New Technologies and Siemens Healthineers Partnership

New advancements in the AiBLE Spine Surgery ecosystem build upon the company's commitment to procedural innovation and execution

Axlab, Danish Medtech Pioneer, expands to US with Advanced Robotic Tissue Sectioning for Pathology Laboratories

Kris Rokke, National Sales Director for Axlab in the US. "My team and I are extremely excited and honored about this unique opportunity to also offer this advanced technology to labs across the US and thus contribute to the pathology labs of tomorrow."

Spartan Medical Broadens Single-Use Sterile Instrument Portfolio to Improve Outcomes, Increase Efficiency, and Generate Cost Savings

Spartan Medical products portfolio of single-use, sterile med tech includes micro and minor surgical convenience kits, kerrison rongeurs, spinal and general surgical retractors, dural repair kits, synthetic biologics, and a wide range of orthopedic pre-sterilized implants and devices.

Recor Medical Supports European Society of Cardiology’s Hypertension Guidelines

Record Medical notes the new guidelines, "2024 ESC Guidelines for the management of elevated blood pressure and hypertension," have been published online and recommend the consideration of renal denervation (RDN) as a safe and effective treatment option for patients who have uncontrolled resistant hypertension or those that have uncontrolled hypertension with a higher risk of cardiovascular disease, who express a preference to undergo RDN.

ConTIPI Medical Selects EVERSANA to Support U.S. Commercialization of Non-Surgical Medical Device ProVate for Women with Pelvic Organ Prolapse

EVERSANA is a leading provider of global commercial services to the life sciences industry, to support commercialization for the ProVate device in the United States to help women experiencing pelvic organ prolapse.